Participant Protection in Phase 1 Pediatric Cancer Trials
This Viewpoint describes changes in the regulatory environment for phase 1 research involving children and discusses improvements to patient protection.
Related Articles
Effect of Medicaid Cuts on the Medical Care Ecosystem
This Viewpoint explores the widespread effects cuts to Medicaid funding could have on the US medical system, including limitations on states, hospitals, and physicians, as…
The Failure of Life Expectancy to Fully Rebound to Prepandemic Levels
This study uses data from the California Comprehensive Death Files to examine how California life expectancy varied by year, income, race and ethnicity, and contributing…
Inflammation in Neuropsychiatric Disorders
This narrative review discusses the uncertainties, challenges, and specific areas of novel research in the growing field of inflammation and adult psychiatric disorders.
High-Touch vs Low-Touch Strategy for Implementing a CRC Screening Digital Health Intervention
This cluster randomized trial examines whether a more intensive implementation strategy resulted in greater use of a mobile app targeting multilevel barriers to colorectal cancer…
Reliability of the Ichthyosis Scoring System in Individuals With Skin of Color
This cross-sectional study assesses the reliability of the Ichthyosis Scoring System in individuals with Fitzpatrick IV to VI skin types.
Cumulative Life’s Essential 8 Scores and Cardiovascular Disease Risk
This cohort study analyzes cardiovascular health data from participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study to determine whether Life’s Essential…
Removable Boot vs Casting of Toddler’s Fractures
This multicenter randomized clinical trial conducted at 4 pediatric Canadian emergency departments determines whether pain in children with toddler’s fractures treated with a removable boot…
Diversified Segmental Defocus Optimization Lenses With and Without Atropine for Myopia Prevention
This randomized clinical trial compares the use of diversified segmental defocus optimization lenses with and without atropine, 0.01%, for the prevention of myopia.
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
This case series study examines the use and outcomes of total neoadjuvant therapy in routine practice for patients with rectal cancer.
Trauma-Informed Care
This JAMA Insights discusses trauma-informed care practices that can help clinicians provide sensitive and supportive care that may improve health outcomes in patients with a…